Back to dashboard
Low impact

Mosunetuzumab-axgb (Lunsumio and Lunsumio Velo) (CPB 1025, reviewed 2026-04-24)

Aetna·Medical Policy
Effective date
Not stated
We identified it
Aug 16, 2026
Days to comply
—

Related policy hubs